Nutriband Inc. (NTRBW)
NASDAQ: NTRBW
· Real-Time Price · USD
1.59
-0.01 (-0.46%)
At close: Sep 05, 2025, 9:30 AM
Nutriband Revenue Breakdown
| Period Ending | Apr 30, 2022 |
|---|---|
| ContractServicesMember Revenue | 75.93K |
| ContractServicesMember Revenue Growth | n/a |
| TransdermalPatchesMember Revenue | 401.99K |
| TransdermalPatchesMember Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Apr 30, 2023 | Oct 31, 2022 | Jul 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 667.43K | 642.38K | 645.8K | 442.83K | 408.53K | 1.18M | 427.84K | 476.93K | 456.15K | 456.15K | 283.04K | 213.74K | 58.04K | n/a | 82.57K | 74.91K | 142.45K |
| United States Revenue Growth | +3.90% | -0.53% | +45.83% | +8.40% | -65.39% | +175.93% | -10.29% | +4.56% | 0.00% | +61.16% | +32.42% | +268.24% | n/a | -100.00% | +10.22% | -47.41% | n/a |
Operating Expense Breakdown
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 973.59K | 1.75M | 725.72K | 726.59K | 1.07M | 913.2K | 1.33M | 678.74K | 839.73K | 1.19M | 1.05M | 908.17K | 768.55K | 1.45M | 1.49M | 509.22K | 579.61K | 2.37M | 203.98K | 193.33K | 191.92K | 509.44K | 307.01K | 406.57K | 567.96K | 516.2K | 445.15K | 1.88M | 448.1K | -64.36K | 107.73K | 92.96K | 35.62K | 33.58K | 29.98K | 35.62K | 52.08K | 400 | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | -44.30% | +140.86% | -0.12% | -32.04% | +17.08% | -31.39% | +96.09% | -19.17% | -29.42% | +13.36% | +15.57% | +18.17% | -46.89% | -2.66% | +191.97% | -12.14% | -75.52% | +1060.94% | +5.51% | +0.74% | -62.33% | +65.93% | -24.49% | -28.42% | +10.03% | +15.96% | -76.31% | +319.28% | -796.18% | -159.75% | +15.89% | +161.00% | +6.08% | +12.00% | -15.84% | -31.60% | +12920.25% | n/a | n/a | n/a |
| Research and Development Revenue | 683.43K | 489.86K | 880.77K | 773.98K | 974.53K | 563.37K | 551.5K | 445.12K | 400.43K | 295.83K | 290.72K | 277.87K | 117.81K | 250.38K | 161K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | +39.52% | -44.38% | +13.80% | -20.58% | +72.98% | +2.15% | +23.90% | +11.16% | +35.36% | +1.76% | +4.62% | +135.85% | -52.95% | +55.52% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |